158 related articles for article (PubMed ID: 3456202)
1. CA 125 surveillance and second-look laparotomy in ovarian carcinoma.
Atack DB; Nisker JA; Allen HH; Tustanoff ER; Levin L
Am J Obstet Gynecol; 1986 Feb; 154(2):287-9. PubMed ID: 3456202
[TBL] [Abstract][Full Text] [Related]
2. Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer.
Jäger W; Adam R; Wildt L; Lang N
Arch Gynecol Obstet; 1988; 243(2):91-9. PubMed ID: 2456743
[TBL] [Abstract][Full Text] [Related]
3. Plasma D-dimer and peritoneal CA-125 levels as predictors of disease status in ovarian carcinoma.
Rose PG; Terrien JM; Baker S
J Surg Oncol; 1994 Jul; 56(3):168-71. PubMed ID: 8028348
[TBL] [Abstract][Full Text] [Related]
4. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of second-look laparotomy for patients with epithelial ovarian carcinoma.
Kamura T; Tsukamoto N; Saito T; Kaku T; Matsuyama T; Nakano H
Int J Gynaecol Obstet; 1990 Oct; 33(2):141-7. PubMed ID: 1976547
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of CA 125 and histological findings at second-look laparotomy in ovarian carcinoma.
Meier W; Stieber P; Eiermann W; Schneider A; Fateh-Moghadam A; Hepp H
Gynecol Oncol; 1989 Oct; 35(1):44-6. PubMed ID: 2792900
[TBL] [Abstract][Full Text] [Related]
7. Tumor markers of epithelial and stromal cell origin at second-look laparotomy in ovarian carcinoma.
Tomás C; Kauppila A
Gynecol Oncol; 1992 Jun; 45(3):279-83. PubMed ID: 1612504
[TBL] [Abstract][Full Text] [Related]
8. Use of CA 125 to monitor patients with ovarian epithelial carcinomas.
Podczaski E; Whitney C; Manetta A; Larson JE; Kirk J; Stevens CW; Lyter J; Mortel R
Gynecol Oncol; 1989 May; 33(2):193-7. PubMed ID: 2703180
[TBL] [Abstract][Full Text] [Related]
9. [Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer].
Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
Geburtshilfe Frauenheilkd; 1988 May; 48(5):331-3. PubMed ID: 3165078
[TBL] [Abstract][Full Text] [Related]
10. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
Crombach G; Zippel HH; Würz H
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomy.
Khoo SK; Hurst T; Webb MJ; Dickie GJ; Kearsley JH; Mackay EV
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):765-71. PubMed ID: 3477461
[TBL] [Abstract][Full Text] [Related]
12. OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.
Xu FJ; Yu YH; Daly L; DeSombre K; Anselmino L; Hass GM; Berchuck A; Soper JT; Clarke-Pearson DL; Boyer C
J Clin Oncol; 1993 Aug; 11(8):1506-10. PubMed ID: 8336189
[TBL] [Abstract][Full Text] [Related]
13. Second look laparotomy in the management of malignant epithelial ovarian neoplasias.
Facchini V; Gadducci A; Del Bravo B; Colombi L; Bartolini T; Manfredini C; Fioretti P
Eur J Gynaecol Oncol; 1986; 7(2):122-9. PubMed ID: 3459658
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer.
Niloff JM; Bast RC; Schaetzl EM; Knapp RC
Am J Obstet Gynecol; 1985 Apr; 151(7):981-6. PubMed ID: 3157319
[TBL] [Abstract][Full Text] [Related]
15. The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinoma.
Hørding U; Toftager-Larsen K; Lund B; Dreisler A; Daugaard S; Lundvall F; Knudsen JB; Bock JE
Eur J Gynaecol Oncol; 1994; 15(3):217-21. PubMed ID: 7957327
[TBL] [Abstract][Full Text] [Related]
16. Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses.
Finkler NJ; Benacerraf B; Lavin PT; Wojciechowski C; Knapp RC
Obstet Gynecol; 1988 Oct; 72(4):659-64. PubMed ID: 3047614
[TBL] [Abstract][Full Text] [Related]
17. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
[TBL] [Abstract][Full Text] [Related]
18. The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer.
Niloff JM; Knapp RC; Lavin PT; Malkasian GD; Berek JS; Mortel R; Whitney C; Zurawski VR; Bast RC
Am J Obstet Gynecol; 1986 Jul; 155(1):56-60. PubMed ID: 3460341
[TBL] [Abstract][Full Text] [Related]
19. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
[TBL] [Abstract][Full Text] [Related]
20. CA 125 in the follow-up of patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Eur J Obstet Gynecol Reprod Biol; 1988 Apr; 27(4):335-42. PubMed ID: 3164284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]